Literature DB >> 25586446

Repeated sugammadex usage in a patient with multiple sclerosis: a case report.

Nadir Sinikoglu1, Tolga Totoz2, Funda Gumus2, Onur Karagulle3.   

Abstract

A 42-year-old woman been suffering from multiple sclerosis for 2 years received an emergency laparotomy because of acute pancreatitis. Anesthesia was induced with propofol and fentanil and maintained with nitrous oxide and sevoflurane. Rocuronium was used for tracheal intubation and muscle relaxation. Train of four ratio was monitored for tracing muscle relaxation. Three days later the patient was operated again due to abdominal cavity infection and followed up with "open abdomen strategy" receiving general anesthesia with 3 days intervals. In all of the six general anesthesia procedures in 18 days the patient was successfully reversed with sugammadex.

Entities:  

Keywords:  Multiple sclerosis; Sugammadex

Mesh:

Substances:

Year:  2015        PMID: 25586446     DOI: 10.1007/s00508-014-0696-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  15 in total

1.  Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action.

Authors:  Bertrand Debaene; Benoît Plaud; Marie-Pierre Dilly; François Donati
Journal:  Anesthesiology       Date:  2003-05       Impact factor: 7.892

2.  Clinical management of multiple sclerosis through home telehealth monitoring: results of a pilot project.

Authors:  Aaron P Turner; Mitchell T Wallin; Alicia Sloan; Heidi Maloni; Robert Kane; Lore Martz; Jodie K Haselkorn
Journal:  Int J MS Care       Date:  2013

3.  Desflurane anaesthesia in a patient with multiple sclerosis in total hip replacement.

Authors:  Levent Sahin; Halil F Korkmaz; Mehrican Sahin; Tayfun Aydin; Serdar Toker; Erim Gulcan
Journal:  Arch Med Sci       Date:  2010-12-29       Impact factor: 3.318

4.  Multiple sclerosis and anesthetic implications.

Authors:  Ihab R Dorotta; Armin Schubert
Journal:  Curr Opin Anaesthesiol       Date:  2002-06       Impact factor: 2.706

5.  Population pharmacokinetic-pharmacodynamic analysis for sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade.

Authors:  Huub J Kleijn; Daniel P Zollinger; Michiel W van den Heuvel; Thomas Kerbusch
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

6.  Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.

Authors:  Koen Suy; Karl Morias; Guy Cammu; Pol Hans; Wilbert G F van Duijnhoven; Marten Heeringa; Ignace Demeyer
Journal:  Anesthesiology       Date:  2007-02       Impact factor: 7.892

7.  Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.

Authors:  Adrienn Pongrácz; Szilárd Szatmári; Réka Nemes; Béla Fülesdi; Edömér Tassonyi
Journal:  Anesthesiology       Date:  2013-07       Impact factor: 7.892

8.  Anesthetic management of the emergency laparotomy for a patient with multiple sclerosis -A case report-.

Authors:  Ki Hwa Lee; Jang Su Park; Sang Il Lee; Ji Yeon Kim; Kyeong Tae Kim; Won Ju Choi; Jeong Won Kim
Journal:  Korean J Anesthesiol       Date:  2010-11-25

9.  Anaesthetic management in a patient with multiple sclerosis.

Authors:  Lata M Kulkarni; Cs Sanikop; Hl Shilpa; Anupama Vinayan
Journal:  Indian J Anaesth       Date:  2011-01

10.  Multiple sclerosis: pathogenesis and treatment.

Authors:  Ingrid Loma; Rock Heyman
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

View more
  1 in total

1.  Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis.

Authors:  Chryssoula Staikou; Martina Rekatsina
Journal:  Saudi J Anaesth       Date:  2017 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.